JP Morgan Chase’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.5M | Sell |
205,248
-519
| -0.3% | -$33.8K | ﹤0.01% | 2197 |
|
|
2026
Q1 | $8.9M | Sell |
205,767
-9,380
| -4% | -$421K | ﹤0.01% | 2795 |
|
|
2025
Q4 | $6.82M | Sell |
215,147
-803,087
| -79% | -$25.1M | ﹤0.01% | 3043 |
|
|
2025
Q3 | $28.7M | Sell |
1,018,234
-420,892
| -29% | -$12.7M | ﹤0.01% | 1805 |
|
|
2025
Q2 | $52.9M | Sell |
1,439,126
-12,982
| -0.9% | -$449K | ﹤0.01% | 1298 |
|
|
2025
Q1 | $57M | Sell |
1,452,108
-347,104
| -19% | -$15.6M | ﹤0.01% | 1238 |
|
|
2024
Q4 | $83.6M | Sell |
1,799,212
-676,061
| -27% | -$30.6M | 0.01% | 1030 |
|
|
2024
Q3 | $112M | Sell |
2,475,273
-450,451
| -15% | -$21.4M | 0.01% | 901 |
|
|
2024
Q2 | $144M | Sell |
2,925,724
-688,179
| -19% | -$28.1M | 0.01% | 774 |
|
|
2024
Q1 | $124M | Sell |
3,613,903
-1,002,170
| -22% | -$36.2M | 0.01% | 845 |
|
|
2023
Q4 | $170M | Sell |
4,616,073
-451,574
| -9% | -$10.4M | 0.02% | 673 |
|
|
2023
Q3 | $103M | Sell |
5,067,647
-68,479
| -1% | -$1.5M | 0.01% | 808 |
|
|
2023
Q2 | $105M | Buy |
5,136,126
+1,078,814
| +27% | +$16.2M | 0.01% | 800 |
|
|
2023
Q1 | $61.2M | Buy |
4,057,312
+162,161
| +4% | +$3.58M | 0.01% | 1003 |
|
|
2022
Q4 | $92.7M | Buy |
3,895,151
+626,497
| +19% | +$18.2M | 0.01% | 801 |
|
|
2022
Q3 | $115M | Buy |
3,268,654
+64,671
| +2% | +$2.75M | 0.02% | 667 |
|
|
2022
Q2 | $112M | Buy |
3,203,983
+1,097,546
| +52% | +$38.9M | 0.02% | 708 |
|
|
2022
Q1 | $104M | Buy |
2,106,437
+293,789
| +16% | +$16.3M | 0.01% | 813 |
|
|
2021
Q4 | $140M | Buy |
1,812,648
+407
| +0% | +$41.8K | 0.02% | 720 |
|
|
2021
Q3 | $194M | Buy |
1,812,241
+29,926
| +2% | +$3.43M | 0.02% | 586 |
|
|
2021
Q2 | $237M | Sell |
1,782,315
-7,912
| -0.4% | -$920K | 0.03% | 549 |
|
|
2021
Q1 | $222M | Sell |
1,790,227
-19,178
| -1% | -$2.91M | 0.03% | 541 |
|
|
2020
Q4 | $256M | Sell |
1,809,405
-750,136
| -29% | -$83.2M | 0.04% | 453 |
|
|
2020
Q3 | $202M | Sell |
2,559,541
-568,140
| -18% | -$35.4M | 0.03% | 480 |
|
|
2020
Q2 | $142M | Buy |
3,127,681
+424,622
| +16% | +$15.2M | 0.03% | 533 |
|
|
2020
Q1 | $82.7M | Buy |
2,703,059
+118,008
| +5% | +$3.17M | 0.02% | 630 |
|
|
2019
Q4 | $54.3M | Buy |
2,585,051
+189,070
| +8% | +$4.42M | 0.01% | 920 |
|
|
2019
Q3 | $57.2M | Buy |
2,395,981
+398,124
| +20% | +$11.6M | 0.01% | 882 |
|
|
2019
Q2 | $56.2M | Buy |
1,997,857
+947,399
| +90% | +$25.1M | 0.01% | 903 |
|
|
2019
Q1 | $24.4M | Buy |
1,050,458
+93,144
| +10% | +$2.1M | 0.01% | 1405 |
|
|
2018
Q4 | $22.1M | Buy |
+957,314
| New | +$21.2M | 0.01% | 1411 |
|
Other funds holding TWST
AIM
EIG
JP Morgan Chase's TWST Position: Q2 2026 in Review
JP Morgan Chase reduced its Twist Bioscience (TWST) stake by 0.25% in Q2 2026, selling an estimated $33.8K and leaving 205,248 shares worth $20.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2197.
JP Morgan Chase first reported a position in TWST in Q4 2018 and has held it in 31 quarters since. The position peaked at $256M in Q4 2020. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- JP Morgan Chase held 205,248 shares of Twist Bioscience worth $20.5M as of Q2 2026.
- JP Morgan Chase sold 519 Twist Bioscience shares in Q2 2026, an estimated $33.8K.
- Twist Bioscience made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2197 holding.
- JP Morgan Chase first reported a position in Twist Bioscience in Q4 2018 and has held it in 31 quarters since.
- JP Morgan Chase's Twist Bioscience position peaked at $256M in Q4 2020.
- 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.